Baldicantos, Baby Boy .
HRN: 24-25-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2023
AMPICILLIN 250MG (VIAL)
12/23/2023
12/29/2023
IV
150mg
Q12h
Potentially Septic Newborn
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes